Based on the data provided, OMAB is not a strong buy for a beginner, long-term investor at this moment. While the company has shown positive financial growth and bullish technical indicators, the lack of significant trading signals, neutral sentiment from hedge funds and insiders, and no major positive catalysts suggest that waiting for a clearer entry point or additional positive developments may be prudent.
The stock shows bullish technical indicators with a positive MACD histogram (0.703), bullish moving averages (SMA_5 > SMA_20 > SMA_200), and a neutral RSI (55.755). The pre-market price is $114.19, up 0.58%, and the stock is trading above its pivot level of $110.997, with resistance levels at $116.179 and $119.38.

The company's financials for Q4 2025 show strong growth, with revenue up 9.58% YoY, net income up 12.40% YoY, and EPS up 13.33% YoY. Analysts maintain an Overweight rating, and the stock has bullish technical indicators.
Gross margin dropped significantly by -46.28% YoY. Analysts have recently lowered the price target from MXN 305 to MXN 270, citing elevated volatility and limited visibility on jet fuel prices. There is no significant news or trading activity from hedge funds, insiders, or influential figures.
In Q4 2025, OMAB reported revenue growth of 9.58% YoY to $224,854,834.18, net income growth of 12.40% YoY to $66,536,797.89, and EPS growth of 13.33% YoY to $0.17. However, gross margin dropped significantly by -46.28% YoY to 57.43.
Analysts have a mixed stance. Barclays recently lowered the price target from MXN 305 to MXN 270 while maintaining an Overweight rating, citing elevated volatility and limited visibility on jet fuel prices. Earlier in the year, Bradesco BBI upgraded the stock to Outperform with a $120 price target.